HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RFI 641

structure in first source

Also Known As:

RFI-641; RFI641

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - RFI 641: 2
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - RFI 641: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Triazines: 306
    - RFI 641: 2

Experts

1.	Buklan, A: 1 article (04/2003)
2.	Frye, J: 1 article (04/2003)
3.	Gray, B: 1 article (04/2003)
4.	Huntley, C: 1 article (04/2003)
5.	Lenoy, E: 1 article (04/2003)
6.	Lynch, M E: 1 article (04/2003)
7.	Mitelman, S: 1 article (04/2003)
8.	Murphy, T: 1 article (04/2003)
9.	O'Connell, J: 1 article (04/2003)
10.	Quartuccio, S: 1 article (04/2003)

Related Diseases

1.	Respiratory Syncytial Virus Infections 04/01/2003 - "Inhalation efficacy of RFI-641 in an African green monkey model of RSV infection."
2.	Infections 04/01/2003 - "The results of this study demonstrate the ability of RFI-641 to reduce the viral load of RSV after inhalation exposure in the primate model of respiratory infection."
3.	Respiratory Tract Infections (Respiratory Tract Infection) 07/01/2001 - "RFI-641, a small dendrimer-like compound, is a potent and selective inhibitor of respiratory syncytial virus (RSV), which is currently a clinical candidate for the treatment of upper and lower respiratory tract infections caused by RSV. "

Related Drugs and Biologics

1.	Dendrimers (Dendrons)